NIH-supported clinical trial of phage therapy for cystic fibrosis begins

The trial is evaluating whether the bacteriophage therapy is safe and able to reduce the amount of bacteria in the lungs of volunteers.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news